Burke SK - Search Results

1

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.

Raggi P, James G, Burke SK, Bommer J, Chasan-Taber S, Holzer H, Braun J, Chertow GM. Raggi P, et al. Among authors: burke sk. J Bone Miner Res. 2005 May;20(5):764-72. doi: 10.1359/JBMR.041221. Epub 2004 Dec 20. J Bone Miner Res. 2005. PMID: 15824849 Free article. Clinical Trial.

2

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM. Raggi P, et al. Among authors: burke sk. J Am Coll Cardiol. 2002 Feb 20;39(4):695-701. doi: 10.1016/s0735-1097(01)01781-8. J Am Coll Cardiol. 2002. PMID: 11849871 Free article.

3

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Chertow GM, Burke SK, Raggi P; Treat to Goal Working Group. Chertow GM, et al. Among authors: burke sk. Kidney Int. 2002 Jul;62(1):245-52. doi: 10.1046/j.1523-1755.2002.00434.x. Kidney Int. 2002. PMID: 12081584 Free article. Clinical Trial.

4

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.

Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD. Chertow GM, et al. Among authors: burke sk. Am J Nephrol. 2003 Sep-Oct;23(5):307-14. doi: 10.1159/000072822. Epub 2003 Aug 12. Am J Nephrol. 2003. PMID: 12915774 Clinical Trial.

5

Determinants of progressive vascular calcification in haemodialysis patients.

Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Chertow GM, et al. Among authors: burke sk. Nephrol Dial Transplant. 2004 Jun;19(6):1489-96. doi: 10.1093/ndt/gfh125. Epub 2004 Apr 21. Nephrol Dial Transplant. 2004. PMID: 15102961

6

Novel dosage forms and regimens for sevelamer-based phosphate binders.

Duggal A, Hanus M, Zhorov E, Dagher R, Plone MA, Goldberg J, Burke SK. Duggal A, et al. Among authors: burke sk. J Ren Nutr. 2006 Jul;16(3):248-52. doi: 10.1053/j.jrn.2006.04.006. J Ren Nutr. 2006. PMID: 16825030 Review.

7

Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients.

Burke SK, Dillon MA, Hemken DE, Rezabek MS, Balwit JM. Burke SK, et al. Adv Ren Replace Ther. 2003 Apr;10(2):133-45. doi: 10.1053/jarr.2003.50016. Adv Ren Replace Ther. 2003. PMID: 12879374

8

The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.

Cozzolino M, Dusso AS, Liapis H, Finch J, Lu Y, Burke SK, Slatopolsky E. Cozzolino M, et al. Among authors: burke sk. J Am Soc Nephrol. 2002 Sep;13(9):2299-308. doi: 10.1097/01.asn.0000025782.24383.0d. J Am Soc Nephrol. 2002. PMID: 12191974 Free article.

9

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.

Katsumata K, Kusano K, Hirata M, Tsunemi K, Nagano N, Burke SK, Fukushima N. Katsumata K, et al. Among authors: burke sk. Kidney Int. 2003 Aug;64(2):441-50. doi: 10.1046/j.1523-1755.2003.00126.x. Kidney Int. 2003. PMID: 12846739 Free article.

10

Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.

Cozzolino M, Staniforth ME, Liapis H, Finch J, Burke SK, Dusso AS, Slatopolsky E. Cozzolino M, et al. Among authors: burke sk. Kidney Int. 2003 Nov;64(5):1653-61. doi: 10.1046/j.1523-1755.2003.00284.x. Kidney Int. 2003. PMID: 14531797 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters